Cytiva exec talks industry trends and challenges at BIO International Convention
By
Josh Abbott
6d agoen
Source
bioprocessintl.comCytiva exec talks industry trends and challenges at BIO International Conventionbioprocessintl.comPierre-Alain Ruffieux discusses emerging modalities, AI-driven development, supply chain resilience, and the growing influence of East Asian innovation in biotech.
You might also wanna read
Global Briefing: AI CEOs Warn of Bioweapon Risks, Israel-Lebanon Ceasefire, Japan Fertility Crisis
This article covers multiple major global stories: AI CEOs (Demis Hassabis, Dario Amodei, Sam Altman) jointly warning about AI's potential b
How AI and Emerging Biotechnologies Are Reshaping Global Biological Security Risks
The article examines how emerging biotechnologies like AI, synthetic biology, and biomanufacturing are reshaping the biological risk landsca
European biotech leaders explore China's role in global life sciences innovation at Paris roundtable
A roundtable discussion in Paris examined China's evolving role in the global biotechnology ecosystem, focusing on how European life science
China's biotech rise: A case study in multiple myeloma drug development
This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc

STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
STAT·1d ago
How AI Will Transform Biopharma: The Sequence of Change Matters
Ben Liu, CEO of Formation Bio, argues that AI will transform the pharmaceutical industry unevenly and sequentially. Some parts of drug disco

Comments
Sign in to join the conversation.
No comments yet. Be the first.